A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill

Abstract

While the administration of enteral IMN to a general, critically ill population did not affect mortality, those patients in whom it was possible to achieve early enteral nutrition with Impact had a significant reduction in the morbidity of their critical illness.